ioDisease Model
ioGlutamatergic Neurons MAPT N279K/N279K™
cat no. io1014
Order now
ioDisease Model
ioSkeletal Myocytes DMD Exon 52 Deletion™
cat no. io1019
Order now
ioDisease Model
ioSkeletal Myocytes DMD Exon 44 Deletion™
cat no. io1018
Order now
ioDisease Model
ioGlutamatergic Neurons PRKN R275W/R275W™
cat no. io1020
Order now
ioDisease Model
ioGlutamatergic Neurons PRKN R275W/WT™
cat no. io1013
Order now
ioDisease Model
ioGlutamatergic Neurons GBA null/WT™
cat no. io1007
Order now
ioDisease Model
ioGlutamatergic Neurons TDP‑43 M337V/M337V™
cat no. ioEA1005
Order now
ioDisease Model
ioGlutamatergic Neurons TDP‑43 M337V/WT™
cat no. ioEA1006
Order now
ioDisease Model
ioGlutamatergic Neurons MAPT N279K/WT™
cat no. io1009
Order now
ioDisease Model
ioGlutamatergic Neurons MAPT P301S/WT™
cat no. io1015
Order now
ioDisease Model
ioGlutamatergic Neurons MAPT P301S/P301S™
cat no. io1018
Order now
ioDisease Model
ioGlutamatergic Neurons HTT 50CAG/WT™
cat no. ioEA1004
Order now
Wild type and isogenic disease model cells: A true comparison
Be confident in your data by pairing ioDisease Model Cells with the genetically matched ioWild Type control.
The right human model
Are you seeking to solve the paucity of successful treatments for neurodegenerative disease? Learn how ioDisease Model Cells are being used as a physiologically-relevant CNS model for drug discovery that will reproducibly scale to high-throughput screens.
“Ultimately, we hope our ioDisease Model Cells will help provide more effective therapies for neurodegenerative diseases such as Huntington’s disease. I believe that it is crucial to use the right human model to successfully translate research into the clinic and help patients”
Tony Oosterveen PhD
bit.bio
A next-generation approach to study Huntington’s disease
Learn about the benchtop benefits and applications of our latest disease model for Huntington’s disease, ioGlutamatergic Neurons HTT 50CAG/WT.
Addressing current challenges of in vitro cell models
Discover how experts from across academia and industry are approaching the challenges of accuracy and reproducibility of in vitro cell models as well as potential solutions.
“For translational applications, it’s important to identify a model that is relevant, which is mirroring the human disease”
Davide Danovi PhD
King’s College London
_MAP2(R)_DAPI(B)_%20(1).png?width=600&height=378&name=a-HTT50CAGWT_Overlay__TUBB3(G)_MAP2(R)_DAPI(B)_%20(1).png)
Don’t see what you’re looking for?
Partner with us. Access our platform to generate custom precision reprogrammed disease model cells to precisely answer your drug discovery, cell therapy or disease research questions.
